MediWound (MDWD) Return on Capital Employed (2016 - 2025)
MediWound's (MDWD) quarterly Return on Capital Employed came in at 39.09% in Q4 2025, up 169.0% year-on-year from 14.53% in Q4 2024, and up 9.67% quarter-over-quarter from 43.28% in Q3 2025.
MediWound (MDWD) Return on Capital Employed (2016 - 2025) Analysis & Trends
MediWound's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 39.09% for Q4 2025.
- On a quarterly basis, Return on Capital Employed rose 169.0% year-over-year to 39.09% in Q4 2025; TTM through Dec 2025 was 39.09%, a 169.0% increase from a year earlier, with the FY2025 full-year figure at 46.64%, down 198.0% from the prior year.
- Return on Capital Employed rose to 39.09% in Q4 2025 per MDWD's latest filing, from 43.28% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 19.18% in Q3 2023 and bottomed at 106.59% in Q1 2022.
- The 5-year median for Return on Capital Employed is 42.4% (2025), against an average of 51.35%.
- Across the five-year window, Return on Capital Employed slumped 6908 bps in 2021 and jumped 8021 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 104.54% in 2021, then soared by 71 bps to 30.63% in 2022, then declined by 3 bps to 31.45% in 2023, then decreased by 30 bps to 40.78% in 2024, then gained by 4 bps to 39.09% in 2025.
- Per Business Quant, the three latest MDWD Return on Capital Employed figures stand at 39.09% (Q4 2025), 43.28% (Q3 2025), and 56.82% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | -39.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.09% |
| Sep 30, 2025 | -43.28% |
| Jun 30, 2025 | -56.82% |
| Mar 31, 2025 | -42.28% |
| Dec 31, 2024 | -40.78% |
| Sep 30, 2024 | -42.52% |
| Jun 30, 2024 | -40.66% |
| Mar 31, 2024 | -34.84% |
| Dec 31, 2023 | -31.45% |
| Sep 30, 2023 | -19.18% |
| Jun 30, 2023 | -20.11% |
| Mar 31, 2023 | -26.62% |
| Dec 31, 2022 | -30.63% |
| Sep 30, 2022 | -88.35% |
| Jun 30, 2022 | -100.32% |
| Mar 31, 2022 | -106.59% |
| Dec 31, 2021 | -104.54% |
| Sep 30, 2021 | -68.50% |
| Jun 30, 2021 | -47.81% |
| Mar 31, 2021 | -42.63% |